RNA m6A Methylation Regulates CDH6 to Promote Epithelial-to-Mesenchymal Transition in Cholangiocytes of Biliary Atresia

In brief

This research investigates how N6-methyladenosine (m6A) RNA modification regulates the CDH6 gene to drive epithelial-to-mesenchymal transition in cholangiocytes affected by biliary atresia. The study elucidates molecular mechanisms underlying this rare pediatric liver disease, potentially identifying therapeutic targets.

• N6-methyladenosine (m6A) RNA modification plays a mechanistic role in biliary atresia pathogenesis.
• m6A methylation regulates CDH6 expression to drive epithelial-to-mesenchymal transition in BA cholangiocytes.
• EMT in cholangiocytes represents a key pathologic process in biliary atresia progression.
• Targeting m6A-CDH6 axis may offer novel therapeutic strategies for biliary atresia management.

Written by the GCMD Library team from the article.